A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2002
11/27/2002	CN1381260A Dropping pill of pueraria flavone and its preparing process
11/27/2002	CN1381259A Medicine for treating diseases of rectum and anus
11/27/2002	CN1381258A Xinnaoshutong ketone and its preparing process
11/27/2002	CN1381257A Chinese-medicinal antihypertensive pillow
11/27/2002	CN1381238A Injection for treating pile and fistula and its preparing process
11/27/2002	CN1381237A Extract for treating cardiovascular and cerebrovascular diseases
11/27/2002	CN1381236A Medicinal composition containing baicalin and caffoeoylchinic acid
11/27/2002	CN1381205A Antihypertensive beverage prepared by microalternative bioelectric field
11/27/2002	CN1381204A Beverage prepared by microalternative bioelectric field for dredging blood vessel and reducing blood fat
11/27/2002	CN1094931C Antithrombotic organic nitrates
11/27/2002	CN1094758C Modulation of calcium channels
11/26/2002	US6486342 Substituted chiral allosteric hemoglobin modifiers
11/26/2002	US6486322 Azaindole derivatives, process for their preparation, and their use as antitumor agents
11/26/2002	US6486315 Recrystallization processes
11/26/2002	US6486299 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
11/26/2002	US6486207 Compositions and methods for amelioration of human female sexual dysfunction
11/26/2002	US6486205 Mixture of primary fatty acids obtained from sugar cane wax
11/26/2002	US6486189 Five-membered heterocycles having biphenylsulfonyl substitution, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
11/26/2002	US6486188 Method of treatment for cardiovascular complications
11/26/2002	US6486186 Thiazole compounds as cyclic AMP-specific phosphodiesterase inhibitors and method of using the same
11/26/2002	US6486182 Mutual prodrugs of amlodipine and atorvastatin
11/26/2002	US6486177 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
11/26/2002	US6486163 Thienopyranecarboxamide derivatives
11/26/2002	US6486154 (Hetero) aryl-sulfonamide derivatives, their preparation and their use as factor XA inhibitors
11/26/2002	US6486143 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds
11/26/2002	US6486142 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
11/26/2002	US6486141 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
11/26/2002	US6486137 Oligosaccharide mixtures having antithrombotic activity
11/26/2002	US6486122 Methods of increasing body weight in a subject by administering TGF-α
11/26/2002	US6485755 Methods of using electron active compounds for managing cancer
11/26/2002	US6485745 Dosage form exhibits accelerated release of the active agent
11/26/2002	US6485727 Method for treatment of chronic venous insufficiencies using an extract of red vine leaves
11/26/2002	US6485704 Azo compound for type I pototherapy
11/26/2002	CA2228635C Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/26/2002	CA2111573C Cadherin materials and methods
11/26/2002	CA2098838C Liver enriched transcription factor
11/26/2002	CA2078555C Novel vitamin d analogues
11/25/2002	WO2001090087A1 Heterocyclic compounds
11/25/2002	CA2410382A1 Heterocyclic compounds
11/24/2002	CA2387007A1 Therapies for tissue damage resulting from ischemia
11/22/2002	WO2001090079A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
11/22/2002	CA2410304A1 Novel carbamates and ureas production and use thereof as endothelin receptor antagonists
11/21/2002	WO2002093177A2 Assays for identifying modulators of rhomboid polypeptides
11/21/2002	WO2002092831A2 Method for identifying ligands for g protein coupled receptors
11/21/2002	WO2002092796A1 Papilloma pseud-virus and it's preparation
11/21/2002	WO2002092781A2 Peptide compounds for counteracting reactive oxygen species and free radicals
11/21/2002	WO2002092759A2 Molecules for disease detection and treatment
11/21/2002	WO2002092667A1 Biodegradable polyphosphates for controlled release of bioactive substances
11/21/2002	WO2002092630A1 High density lipoprotein-reactive peptides
11/21/2002	WO2002092622A2 Dipeptide derivatives having a n-terminal 2-thioacyl group as vasopeptidase inhibitors
11/21/2002	WO2002092614A1 Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof
11/21/2002	WO2002092597A1 The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.0?2,11.04.9¿)-hexadeca-2.(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002	WO2002092596A1 Novel sulfonate substituted pyrazol pyridine dervivatives
11/21/2002	WO2002092593A1 4-(4-pyridazinyl)pyrazole derivatives
11/21/2002	WO2002092590A1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
11/21/2002	WO2002092588A2 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002	WO2002092582A1 Protease-inhibitors
11/21/2002	WO2002092576A1 Diarylurea derivatives useful as anti-inflammatory agents
11/21/2002	WO2002092568A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002	WO2002092567A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
11/21/2002	WO2002092553A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors
11/21/2002	WO2002092550A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii
11/21/2002	WO2002092540A1 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsatruated fatty acids from microbes, genetically modified plant seeds and marine organisms
11/21/2002	WO2002092122A2 Use of osteopontin for the treatment and/or prevention of neurologic diseases
11/21/2002	WO2002092119A1 Method of modulating the activity of calcium channels in cardiac cells and reagents therefor
11/21/2002	WO2002092109A1 Herbal composition and its use
11/21/2002	WO2002092104A1 A pharmaceutical composition comprising lysophosphatidic acid
11/21/2002	WO2002092090A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
11/21/2002	WO2002092089A1 Tartrate salts of 5,8,14-triazatetracyclo {10.3.1.0?2,11.04,9¿}-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002	WO2002092087A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002	WO2002092086A1 Imidazo (1,2-a)-pyridine derivatives as mglur5 antagonists
11/21/2002	WO2002092085A1 Pharmaceutical compositions comprising chelidonine or derivatives thereof
11/21/2002	WO2002092084A1 Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes
11/21/2002	WO2002092082A1 Stable high-concentration injection containing pyrazolone derivative
11/21/2002	WO2002092079A1 Utilization of selective indirubin derivatives as vegf-r inhibitors
11/21/2002	WO2002092078A1 Oral controlled release pharmaceutical composition for one-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases
11/21/2002	WO2002092075A2 Therapeutic delivery of carbon monoxide
11/21/2002	WO2002092070A1 Isostearic acid salts as permeation enhancers
11/21/2002	WO2002092068A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/21/2002	WO2002092067A1 Compositions for transmucosal administration containing coenzyme q as the active ingredient
11/21/2002	WO2002092063A2 Utilization of rutins and aescins in the treatment of ocular circulatory disturbances
11/21/2002	WO2002092058A1 Rapidly disintegratable solid preparation
11/21/2002	WO2002092008A2 Use of il-18 inhibitors for the treatement or prevention of sepsis
11/21/2002	WO2002092004A2 Use of hmg fragment as anti-inflammatory agents
11/21/2002	WO2002091993A2 Estrogen receptor modulators
11/21/2002	WO2002091988A2 Novel processes for the preparation of adenosine compounds and intermediates thereto
11/21/2002	WO2002078615A3 Antioxidant nitroxides and nitrones as therapeutic agents
11/21/2002	WO2002074981A3 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
11/21/2002	WO2002072034A3 Chronotherapeutic dosage forms
11/21/2002	WO2002067953A3 Chromium/biotin treatment of dyslipidemia and diet-induced post prandial hyperglycemia
11/21/2002	WO2002067870A3 Composition and method for preventing and treating sinusoidal obstruction syndrome and radiation-induced liver disease
11/21/2002	WO2002063308A3 Prediction of wound healing by urinary nitrate assay
11/21/2002	WO2002062343A3 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO[4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS
11/21/2002	WO2002058733A9 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
11/21/2002	WO2002055514A3 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators
11/21/2002	WO2002049649A3 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
11/21/2002	WO2002018341A9 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors
11/21/2002	WO2002012250B1 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
11/21/2002	WO2001019397A9 Methods and compositions utilizing rad51
11/21/2002	US20020173661 Phosphodiesterase-4 (PDE4); thiazole-containing pyridine (N-oxide) compounds; 4-(2-(3,4-Bis(difluoromethoxy)phenyl)-2-(5-(2-(1-hydroxy-1 -methyl)ethyl)thiazolyl)ethyl)pyridine N-oxide for example

1 ... 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 ... 1595